Literature DB >> 22563776

Tuberculosis in pregnancy: the challenges for South Asian countries.

Narayan Jana1, Sukumar Barik, Nalini Arora, Arun Kumarendu Singh.   

Abstract

AIM: Despite tuberculosis (TB) being a global problem, maternal TB remains an unrecognized and underestimated tragedy, especially in South Asian countries. Therefore, we performed a non-systematic review regarding implications of maternal TB on obstetric and perinatal outcomes in the South Asian context.
MATERIAL AND METHODS: We reviewed original studies, both descriptive and analytical, that originated from South Asian countries following an electronic search supplemented by a manual search. Although relevant studies from developed countries were reviewed, they were not included in the tabulation process because those studies had different socioeconomic/epidemiological background.
RESULTS: Diagnosis of TB is often delayed during pregnancy, because of its non-specific symptoms, and overlapping presentation with other infectious diseases. Poverty, undernutrition, lack of social support and poor health infrastructure along with complications of TB and need for prolonged medications lead to increased maternal morbidity and mortality. Maternal TB in general (except lymphadenitis), is associated with an increased risk of small-for-gestational age, preterm and low-birthweight neonates, and high perinatal mortality. These adverse perinatal outcomes are even more pronounced in women with advanced disease, late diagnosis, and incomplete or irregular drug treatment. There could be a synergy of TB, socioeconomic and nutritional factors, which might have contributed to adverse perinatal effects, especially in low-income countries.
CONCLUSIONS: As active TB poses grave maternal and perinatal risks, early, appropriate and adequate anti-TB treatment is a mainstay for successful pregnancy outcome. The current knowledge gaps in perinatal implications of maternal TB can be addressed by a multicenter comparative cohort study.
© 2012 The Authors. Journal of Obstetrics and Gynaecology Research © 2012 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22563776     DOI: 10.1111/j.1447-0756.2012.01856.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  9 in total

1.  Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.

Authors:  Amita Gupta; Jyoti S Mathad; Susan M Abdel-Rahman; Jessica D Albano; Radu Botgros; Vikki Brown; Renee S Browning; Liza Dawson; Kelly E Dooley; Devasena Gnanashanmugam; Beatriz Grinsztejn; Sonia Hernandez-Diaz; Patrick Jean-Philippe; Peter Kim; Anne D Lyerly; Mark Mirochnick; Lynne M Mofenson; Grace Montepiedra; Jeanna Piper; Leyla Sahin; Radojka Savic; Betsy Smith; Hans Spiegel; Soumya Swaminathan; D Heather Watts; Amina White
Journal:  Clin Infect Dis       Date:  2015-12-09       Impact factor: 9.079

2.  A Community Perspective on the Inclusion of Pregnant Women in Tuberculosis Drug Trials.

Authors:  Lindsay McKenna; Mike Frick; Cynthia Lee; Dorothy Namutamba; Liani Smit; Marie Theunissen; Wim Vandevelde; Suraj Madoori; Kathryn Snow; Barbara Seaworth
Journal:  Clin Infect Dis       Date:  2017-10-15       Impact factor: 9.079

3.  Risk of Adverse Infant Outcomes Associated with Maternal Tuberculosis in a Low Burden Setting: A Population-Based Retrospective Cohort Study.

Authors:  Sylvia M LaCourse; Sharon A Greene; Elizabeth E Dawson-Hahn; Stephen E Hawes
Journal:  Infect Dis Obstet Gynecol       Date:  2016-02-16

4.  Low Prevalence of Active Tuberculosis among High-Risk Pregnant and Postpartum Women in Sweden: A Retrospective Epidemiological Cohort Study Using and Evaluating TST as Screening Method.

Authors:  Maria Bullarbo; Martina Barnisin; Nina Vukas Radulovic; Åsa Mellgren
Journal:  Infect Dis Obstet Gynecol       Date:  2018-07-18

5.  Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-Feeding.

Authors:  Estella Dora Germaine Garessus; Hans Mielke; Ursula Gundert-Remy
Journal:  Front Pharmacol       Date:  2019-01-22       Impact factor: 5.810

6.  Association of tuberculosis treatment with pregnancy complications: A protocol for systematic review and meta-analysis.

Authors:  Moloko A Kgathi; Wendy N Phoswa
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

7.  Massive hemoptysis and complete unilateral lung collapse in pregnancy due to pulmonary tuberculosis with good maternal and fetal outcome: a case report.

Authors:  Gwinyai Masukume; Elton Sengurayi; Phinot Moyo; Julio Feliu; Danboy Gandanhamo; Wedu Ndebele; Solwayo Ngwenya; Rudo Gwini
Journal:  BMC Res Notes       Date:  2013-08-22

8.  Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden.

Authors:  Jerker Jonsson; Sharon Kühlmann-Berenzon; Ingela Berggren; Judith Bruchfeld
Journal:  Eur Respir J       Date:  2020-03-20       Impact factor: 16.671

9.  Clinical analysis of pregnancy complicated with miliary tuberculosis.

Authors:  Kaige Wang; Donghua Ren; Zhixin Qiu; Weimin Li
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.